|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jul 23, 2013 |
Title |
Gene expression data in CD4+ and CD8+ cells in sarcoidosis patients following antimycobacterial therapy |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Many chronic cutaneous diseases associated with microbial antigens demonstrate clinical progression due to T cell hyporesponsiveness. Appropriate antimicrobial therapy restores T cell function, leading to clinical resolution. Due to the association of sarcoidosis with mycobacterial antigens, we compared the efficacy of antimycobacterial therapy with placebo in chronic cutaneous sarcoidosis.
|
|
|
Overall design |
We conducted a randomized, placebo-controlled, single-blind trial on chronic cutaneous sarcoidosis subjects. Participants received the oral CLEAR regimen: Levofloxacin 750 mg on day 1, then 500 mg daily, Ethambutol 1200 mg daily, Azithromycin 500 mg on day 1, then 250 mg daily, and Rifampin 300 mg daily, or a comparative placebo regimen, for a total of 8 weeks, with a 180 day follow-up. Participants were monitored for absolute change in lesion diameter and decrease in granulomas burden upon completion of therapy.
|
|
|
Contributor(s) |
Pandit KV, Drake W, Kaminski N |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Jul 24, 2012 |
Last update date |
Oct 11, 2016 |
Contact name |
Kusum Vijay Pandit |
E-mail(s) |
panditkusum@yahoo.com
|
Phone |
412-624-9046
|
Organization name |
University of Pittsburgh
|
Department |
Medicine-PACCM
|
Street address |
200, Lothrop street, W1200-25A Biomedical Science Tower
|
City |
Pittsburgh |
State/province |
PA |
ZIP/Postal code |
15213 |
Country |
USA |
|
|
Platforms (1) |
GPL14550 |
Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Probe Name Version) |
|
Samples (20)
|
GSM972931 |
CD4+ T cells, baseline, biological replicate 1 |
GSM972932 |
CD4+ T cells, post treatment, biological replicate 1 |
GSM972933 |
CD8+ T cells, baseline, biological replicate 1 |
GSM972934 |
CD8+ T cells, post treatment, biological replicate 1 |
GSM972935 |
CD4+ T cells, baseline, biological replicate 2 |
GSM972936 |
CD4+ T cells, post treatment, biological replicate 2 |
GSM972937 |
CD8+ T cells, baseline, biological replicate 2 |
GSM972938 |
CD8+ T cells, post treatment, biological replicate 2 |
GSM972939 |
CD4+ T cells, baseline, biological replicate 3 |
GSM972940 |
CD4+ T cells, post treatment, biological replicate 3 |
GSM972941 |
CD8+ T cells, baseline, biological replicate 3 |
GSM972942 |
CD8+ T cells, post treatment, biological replicate 3 |
GSM972943 |
CD4+ T cells, baseline, biological replicate 4 |
GSM972944 |
CD4+ T cells, post treatment, biological replicate 4 |
GSM972945 |
CD8+ T cells, baseline, biological replicate 4 |
GSM972946 |
CD8+ T cells, post treatment, biological replicate 4 |
GSM972947 |
CD4+ T cells, baseline |
GSM972948 |
CD4+ T cells, placebo treatment |
GSM972949 |
CD8+ T cells, baseline |
GSM972950 |
CD8+ T cells, placebo treatment |
|
Relations |
BioProject |
PRJNA171238 |
Supplementary file |
Size |
Download |
File type/resource |
GSE39606_RAW.tar |
62.7 Mb |
(http)(custom) |
TAR (of TXT) |
Processed data included within Sample table |
|
|
|
|
|